Patients with Multiple Trauma.
Conditions
Interventions
Intervention 1: Intervention group:1 mg / kg ketamine nebulizer with a maximum dose of 50 mg, which is brought to a volume of 3 cc with distilled water and poured into the nebulizer chamber, and conne
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 64 Years
Inclusion criteria
Inclusion criteria: Trauma patients with trauma pain with a pain score greater than 4 Age over 4 years Age less than 65 years
Exclusion criteria
Exclusion criteria: Patients with level of consciousness 13 Housing consumption in the last 4 hours History of seizures Unsatisfied people to participating in the project Psychedelics and drug addiction Maxillofacial trauma in which the patient is unable to use a nebulizer mask Systolic blood pressure less than 90 and more than 180 Respiratory rate less than 10 pulse rate Less than 60 and more than 140 Suspected of bleeding brain lesions or cerebral edema Pregnancy History of allergies to any of the drugs used in the study Frequent nausea and vomiting Brain Tumor Glaucoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment by reducing the pain intensity by two points (20 mm) in terms of visual analog scale (VAS). Timepoint: Measurement of pain score at the beginning of the study (before the intervention) and 5, 10, 15, 30 and 60 minutes after the start of treatment. Method of measurement: visual analog scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Creating analgesia which patient's intensity pain goes below than 5. Timepoint: Measurement of pain score at the beginning of the study (before the intervention) and 5, 10, 15, 30 and 60 minutes after the start of treatment. Method of measurement: visual analog scale (VAS).;Determining the time to start treatment response in two groups. Timepoint: Measurement of pain score at the beginning of the study (before the intervention) and 5, 10, 15, 30 and 60 minutes after the start of treatment. Method of measurement: visual analog scale (VAS).;Determining the frequency of patients who failed treatment in two groups. Timepoint: At the end of the study. Method of measurement: Calculate the number.;Determine the number of times the drug is prescribed. Timepoint: At the end of the study. Method of measurement: Calculate the number. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rayat Roknabadi
Yazd University of Medical Sciences
Outcome results
None listed